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Peritonitis in patients with end-stage renal disease on 
continuous ambulatory peritoneal dialysis
B Mashiloane, F M Moshesh, M J Mpe
To the Editor: We investigated the experiences with continuous 
ambulatory peritoneal dialysis (CAPD)-related peritonitis in 
patients with end-stage renal disease (ESRD) at the nephrology 
unit of Dr George Mukhari Hospital. In this study population, 
the mortality rate from peritonitis is high, Gram-negative 
sepsis predominates and the recurrence rate was also high. Age 
is a risk factor for mortality.
Background
CAPD is an established therapy for ESRD. No costly 
equipment is required, the technique is easily learned by 
patients, and frequent hospital visits are not necessary. CAPD 
does not immobilise patients for prolonged periods of time, 
requires less rigid fluid and dietary restrictions, and tends to 
preserve residual renal function longer than haemodialysis.1 
Therefore, CAPD is an important option for treatment of ESRD 
in developing countries.2,3
A study from Groote Schuur Hospital, Cape Town, 
found peritonitis to be the major limiting factor for CAPD. 
Increased frequency of peritonitis was associated with poor 
socioeconomic conditions, age and diabetes.2 In contrast, 
peritonitis rates among patients at Chris Hani Baragwanath 
Hospital in Soweto were similar to those of the developed 
world. Socioeconomic factors did not appear to play a role in 
peritonitis rates or CAPD failure.3
The nephrology unit at Dr George Mukhari Hospital has 
experienced increased pressure on the limited number of 
haemodialysis ‘slots’ as a result of decreases in live donor 
transplants and the utilisation of cadaveric donors because of 
the HIV/AIDS epidemic. This has resulted in an expansion of 
the CAPD programme.
Despite increased experience and advances in peritoneal 
dialysis, peritonitis remains a major cause of morbidity 
in patients on long-term CAPD and is the major cause of 
treatment failure and the need to transfer to haemodialysis.2-4
This study documents the recent experience with peritonitis 
in patients receiving CAPD for ESRD in a busy South African 
tertiary hospital.
Methods and study design
Thirty-one patients with ESRD on CAPD, who had peritonitis 
between March 2004 and March 2006, were included. The 
demographic data, primary renal disease, date of Tenckhoff 
catheter insertion, date of commencing renal replacement 
therapy, peritoneal infection, biochemistry and microbiology of 
peritoneal fluid, antimicrobial agents used, mortality rates and 
the glomerular filtration rate were recorded in each case.
Quantitative data are presented as means and standard 
deviation (SD). Qualitative data are summarised in 
percentages. Where comparisons were made, a p-value of 
<0.05 was considered to be indicative of statistically significant 
differences. Comparison of means was done using Student’s 
t-test. Categorical variables were compared using Fisher’s exact 
test.
Results
A total of 40 patients with ESRD on CAPD were admitted 
for peritonitis. Thirty-one files were available for evaluation. 
Females comprised 68% of the patients; the mean age was 
41±22 years, and the mean number of years subsequent to 
catheter insertion before the development of infection was 
1.5±3.1 years. Hypertension was the leading cause of renal 
disease in 21 patients (68%); adult polycystic kidney disease in 
4 (13%); chronic glomerulonephritis and chronic pyelonephritis 
in 2 each (6.5% each); and nephrotic syndrome and unknown 
in 1 (3%) each.
Sixty-five episodes of peritonitis were recorded between 
March 2004 and March 2006. Twenty-one (68%) patients had 
from 2 to 5 episodes of peritonitis during this period. Seven 
patients (27%) had 1 episode, 14 (45%) had 2 episodes, and 10 
(32%) had >3 episodes.
All 31 patients presented with abdominal pain; 52% were 
pyrexial; vomiting occurred in 6 (19%); 84% presented with a 
cloudy dialysate fluid; and in 2, the dialysate fluid was cloudy 
and had strands. In 3 patients, the dialysate fluid was reported 
to be clear.
Most of the episodes (65%) were culture-negative. Klebsiella 
pneumoniae was found in 16%, Gram-positive cocci in 10%, 
other Gram-negative pathogens in 6%, and Candida albicans in 
3%.
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The mean peritoneal fluid polymorphonuclear cell count was 
270±756/µl, and the mean fluid lymphocyte count 240±409 per 
µl. All patients under review had an HIV test, and only 1 (3%) 
was positive.
Ten patients (32%) died during the study period (Table I); 
their age was 47±6.3 years, which was significantly higher than 
that of the survivors (38±10.9) (p=0.0236). Patients who died 
had an average of 2.4 episodes of peritonitis, which was not 
significantly different from those who survived (p=0.2701). The 
male and female mortality rates were similar (5/10 v. 5/21, 
p=0.2220).
Three patients (10%) were transferred to haemodialysis 
owing to multiple episodes (4 on average) of peritonitis and 
intra-abdominal sepsis. One of these 3 patients died. The 
remaining 2 patients continued with haemodialysis.
Serum creatinine ranged from 326 to 1 775 µmol/l (mean  
1 071) and urea from 8.1 to 40.8 mmol/l (mean 22) on 
admission to the programme. High values predict poor 
outcome. Serum albumin concentration ranged from 12 to 
42 g/l (mean 27) and total protein from 39 g/l to 85 g/l 
(mean 61). Patients with normal values had a good outcome. 
Haemoglobin ranged from 7.2 g/l to 14 g/dl (mean 9.5). White 
cell counts ranged from 3.9 to 84.8×109/l (mean 12.2); patients 
with chronic myeloid leukaemia, who both died, had the two 
highest counts.
Discussion
Abdominal pain (the most common presenting symptom in 
our study) was found to be a reliable sign of peritonitis in 
most other studies.8,10,11 The high number of Gram-negative 
pathogens in our study contrasts with others that reported 
high numbers of Gram-positive bacteria.8,9,20 Non-adherence 
to infection control protocols by the training staff and patients 
could have contributed to this finding.
Our mortality rate of 32%, which is higher than the 10 - 20% 
reported mortality rates,9,10,18 may be due in part to the high 
incidence of Gram-negative sepsis9,11 and to late presentation. 
Most patients received intraperitoneal vancomycin and 
amikacin for an average of 10 days. Patients with fungal 
peritonitis were treated with intravenous fluconazole. One 
patient who was allergic to vancomycin received ceftriaxone.
Most patients in our study had culture-negative peritonitis, 
which confirms reports that most cases of peritonitis in this 
setting tend to be culture-negative.10,18,20 Important reasons for 
this include recent antibiotic therapy or technical problems 
during peritoneal dialysate effluent (PDE) culture.5,18 Sewell 
et al. and Eisele et al. found that more than half of patients 
with culture-negative peritonitis had antimicrobial activity 
detected in their PDE.18,19 (It should be noted that prior 
antibiotic usage was not specifically studied in our project.) It 
is probable that some patients were given antibiotics by their 
general practitioner or clinic doctor. Eisele et al. reported that 
surreptitious use of antimicrobial agents was common among 
peritoneal dialysis patients.19 An incidence of more than 50% 
of culture-negative peritonitis was reported by Szeto et al.10 
Other reasons for high negative culture rates are PD exchange 
technique, exit-site care, and growth of fastidious organisms.11,18 
We could not study the effect of HIV as only one patient tested 
positive.
More than one episode of peritonitis occurred in 68% of our 
patients, which is higher than other studies where multiple 
episodes occurred in 18 - 35%.8,9,11,18 Katz et al. reported that 
black patients tended to have high recurrence rates.3 Blacks 
have been shown to have an increased risk of developing 
peritonitis compared with whites, even after adjusting for 
socioeconomic and co-morbid factors.8
Only 2 patients in our study had their dialysis catheter 
removed because of intra-abdominal sepsis. One of these 
patients had peritonitis due to C. albicans and was treated with 
intravenous fluconazole and the dialysis catheter removed 
as part of the standard protocol. Fungal peritonitis is an 
uncommon but potentially life-threatening complication of 
CAPD, with a reported incidence of fungal peritonitis of 3 - 
6%.16
Conclusion
Our study confirms that CAPD is a useful and practical 
alternative to haemodialysis in our setting. However, CAPD-
related peritonitis remains a major threat and carries a high 
mortality rate, especially in older patients. Our findings 
suggest that catheter insertion should be performed by trained 
dialysis unit staff; patients should be educated to present to 
the unit if they experience any abdominal pain; peritoneal 
dialysate fluid should be inoculated directly into blood culture 
bottles; and patients should be told to avoid antibiotics unless 
prescribed by dialysis unit staff.
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